CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors
- Jiawan Wang
- , Ana Calizo
- , Lindy Zhang
- , James C. Pino
- , Yang Lyu
- , Kai Pollard
- , Xiaochun Zhang
- , Alex T. Larsson
- , Eric Conniff
- , Nicolas J. Llosa
- , David K. Wood
- , David A. Largaespada
- , Susan E. Moody
- , Sara J. Gosline
- , Angela C. Hirbe
- , Christine A. Pratilas
- Section of Medical Oncology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Cancer Biology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- Institute of Clinical and Translational Sciences (ICTS)
- Brain Tumor Center
- Bursky Center for Human Immunology and Immunotherapy
- Neurofibromatosis (NF) Center
- Siteman Cancer Center
Research output: Contribution to journal › Article › peer-review
20
Link opens in a new tab
Scopus
citations